Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 18214-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#18214-1-AP, RRID:AB_2262251
- Product name
- CCL28 antibody
- Antibody type
- Polyclonal
- Description
- CCL28 antibody (Cat. #18214-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: FC, IHC, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Transcriptionally activates CCL28 expression to inhibit M2 polarization of macrophages and prevent immune escape in colorectal cancer cells.
Knockdown of CCL28 inhibits endometriosis stromal cell proliferation and invasion via ERK signaling pathway inactivation.
IL-17D affects the chemokines and chemokine receptors of intestinal epithelial cells under hyperoxia.
CCL27/CCL28-CCR10 Chemokine Signaling Mediates Migration of Lymphatic Endothelial Cells.
CCL28 promotes breast cancer growth and metastasis through MAPK-mediated cellular anti-apoptosis and pro-metastasis.
Li S, Zhang N, Yang Y, Liu T
Translational oncology 2024 Feb;40:101842
Translational oncology 2024 Feb;40:101842
Knockdown of CCL28 inhibits endometriosis stromal cell proliferation and invasion via ERK signaling pathway inactivation.
Wu Y, Zhu F, Sun W, Shen W, Zhang Q, Chen H
Molecular medicine reports 2022 Feb;25(2)
Molecular medicine reports 2022 Feb;25(2)
IL-17D affects the chemokines and chemokine receptors of intestinal epithelial cells under hyperoxia.
Li T, Liu Y, Yu X, Wang P, Sun S, Liu D
International immunopharmacology 2022 Dec;113(Pt A):109386
International immunopharmacology 2022 Dec;113(Pt A):109386
CCL27/CCL28-CCR10 Chemokine Signaling Mediates Migration of Lymphatic Endothelial Cells.
Karnezis T, Farnsworth RH, Harris NC, Williams SP, Caesar C, Byrne DJ, Herle P, Macheda ML, Shayan R, Zhang YF, Yazar S, Takouridis SJ, Gerard C, Fox SB, Achen MG, Stacker SA
Cancer research 2019 Apr 1;79(7):1558-1572
Cancer research 2019 Apr 1;79(7):1558-1572
CCL28 promotes breast cancer growth and metastasis through MAPK-mediated cellular anti-apoptosis and pro-metastasis.
Yang XL, Liu KY, Lin FJ, Shi HM, Ou ZL
Oncology reports 2017 Sep;38(3):1393-1401
Oncology reports 2017 Sep;38(3):1393-1401
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- human spleen tissue were subjected to SDS PAGE followed by western blot with 18214-1-AP(CCL28 antibody) at dilution of 1:300
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human colon using 18214-1-AP(CCL28 antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The CCL28 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human CCL28. This antibody recognizes human, mouse antigen. The CCL28 antibody has been validated for the following applications: ELISA, WB, IHC analysis.
